Interpace Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	50	12	5	4	31	13
Market Cap Growth	304.54%	152.98%	5.76%	-85.77%	145.72%	-33.55%
Enterprise Value	51	63	60	58	87	53
Last Close Price	1.80	2.70	1.08	1.04	7.47	3.14
PE Ratio	16.59	1.90	2.40	-	-	-
PS Ratio	1.19	0.25	0.12	0.14	0.94	0.39
PB Ratio	-167.29	-5.35	-0.52	-0.27	7.57	0.73
P/FCF Ratio	11.25	3.15	1.41	-	-	-
P/OCF Ratio	10.22	2.56	1.24	-	-	-
EV/Sales Ratio	1.21	1.35	1.49	1.82	2.62	1.63
EV/EBITDA Ratio	9.06	7.55	11.97	-	-	-
EV/EBIT Ratio	11.10	7.83	15.07	-	-	-
EV/FCF Ratio	11.44	16.84	18.00	-	-	-
Debt / Equity Ratio	-7.58	-2.64	-1.24	-0.97	2.60	0.27
Debt / EBITDA Ratio	0.40	0.64	1.93	-	34.59	-
Debt / FCF Ratio	0.51	1.55	3.37	-	-	-
Net Debt / Equity Ratio	-2.81	-1.98	-0.85	-0.68	1.96	0.11
Net Debt / EBITDA Ratio	0.17	0.52	1.54	-8.80	-20.65	-0.11
Net Debt / FCF Ratio	0.19	1.17	2.32	-1.40	-0.89	-0.13
Asset Turnover	3.22	3.36	2.75	1.17	0.79	0.67
Inventory Turnover	13.70	13.95	12.22	13.28	9.95	11.18
Quick Ratio	1.24	0.94	0.75	0.69	0.47	0.59
Current Ratio	1.54	1.11	0.91	0.85	0.78	0.78
Return on Equity (ROE)	-	-	-	-	-65.25%	-133.86%
Return on Assets (ROA)	21.90%	36.32%	17.03%	-8.82%	-8.57%	-30.83%
Return on Invested Capital (ROIC)	462.35%	1864.97%	-	-111.35%	-36.49%	-104.49%
Return on Capital Employed (ROCE)	75.00%	194.10%	235.90%	-226.40%	-25.30%	-87.40%
Earnings Yield	6.69%	56.45%	41.64%	-494.86%	-47.92%	-208.43%
FCF Yield	8.89%	31.75%	70.72%	-180.61%	-29.10%	-122.56%
Buyback Yield / Dilution	-654.43%	-260.54%	-2.97%	-2.49%	-2.63%	-7.56%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.